BF Biosciences Limited (PSX: BFBIO) Thursday announced that its combi filling and lyophilization lines have been commissioned and commercial production has commenced.
In a notice to the Pakistan Stock Exchange (PSX), citing an earlier communication, the company said that secured approval from Drug Regulatory of Pakistan (DRAP) for its brownfield expansion project along with commencement of commercial production from pre-filled syringes line.
“In continuation of the above, we are pleased to inform that the combi filling and lyophilization lines have been commissioned and commercial production has commenced. Accordingly, the full Line Il expansion project stands commissioned from today,” it said.
Moreover, the company said it has already secured approvals for new products from DRAP and intends to launch these products in the coming months.
Follow ProPakistani on Google News & scroll through your favourite content faster!
Support independent journalism
If you want to join us in our mission to share independent, global journalism to the world, we’d love to have you on our side. If you can, please support us on a monthly basis. It takes less than a minute to set up, and you can rest assured that you’re making a big impact every single month in support of open, independent journalism. Thank you.
